VB

Vimee Bindra

Active Director Director DIN 08550448
DIN 08550448 First appointment Aug 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Vimee Bindra

Data last updated:

Vimee Bindra is a Director at Cope Health Care And Research Private Limited (since 2019). The company operates in Healthcare. Cope Health Care And Research Private Limited reported revenue of ₹71.8 Lakh (FY 2024).

DIN 08550448
Primary Designation Director
Industry Healthcare
First Appointment 30 Aug 2019
Oldest Company Age 7 yrs
Largest company Cope Health Care And Research Private Limited · ₹71.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Aug 20192019₹71.8 Lakh (FY 2024)Active

Board colleagues of Vimee Bindra

Directorship timeline

Open interactive timeline →
Cope Health Care And Research Private Limited
Premium access

Shareholding and investment profile for Vimee Bindra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vimee Bindra

Vimee Bindra currently holds 1 directorship: Cope Health Care And Research Private Limited (Director, since 30 Aug 2019, revenue ₹71.8 Lakh (FY 2024)).

Vimee Bindra was first appointed on 30 Aug 2019 as Director at Cope Health Care And Research Private Limited.

The current boards of Vimee Bindra's companies include Archana Reddy Cheruku (Cope Health Care And Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available